Browse by Medical Category
Accepting New Patients
Dr. David Louis is Benjamin Castleman Professor of Pathology and chair of Mass General Pathology. His clinical practice and research focuses on the molecular basis of brain tumors and the application of molecular diagnostics to their classification.
Go To Programs
Go To Specialties
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
David N. Louis, MD, is the Benjamin Castleman Professor of Pathology at HMS and Pathologist-in-Chief at MGH. Under Dr. Louis, the department has become a national leader in molecular diagnostics and pathology informatics, leading to a novel initiative in computational pathology. Dr. Louis' own neuropathology practice and research focuses on brain tumors, with an emphasis on the molecular basis of malignant gliomas and the application of molecular diagnostics to glioma classification. He has published nearly 300 original articles, as well as numerous reviews, chapters and books (h-index = 99). His laboratory was the first to demonstrate that molecular approaches could be used to classify malignant gliomas and that molecular approaches could be used to predict the response of malignant gliomas to specific therapies. Dr. Louis co-chaired and was the primary editor for the 2007 and the 2016 WHO Classification of Tumours of the Central Nervous System, is currently chairing the CNS tumor committee for the International Collaboration on Cancer Reporting, and is the founder and inaugural Steering Committee chair for cIMPACT-NOW (the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy). He has served as chair of the Scientific Advisory Panel of the Brain Tumor Society, on the Board of Directors of the Society for Neuro-Oncology, and on editorial boards of more than 10 national and international journals. Dr. Louis was one of three editors for the 8th edition of Greenfield's Neuropathology and was first author of AFIP Fascicle on Non-neoplastic Disease of the Central Nervous System. He was co-chair of the NIH Brain Tumor Progress Review Group and founding chair of the Cancer Biomarkers Study Section at NIH.
View my most recent publications at PubMed
2005 - Histology-Based Expression Profiling Yields Novel Prognostic Markers in Human Glioblastoma - JNEN (PDF)Supplementary Information Table 1.xls Supplementary Information Table 2.xls Supplementary Information Table 3.xls
View article on PubMed
The 70th meeting of the MGH Scientific Advisory Committee focused on the MGH Research Institute, which was founded in 2015 as an organizational home for the more than 8,500 MGHers in 30 departments, centers and institutes who make up the largest hospital-based research program in the U.S.
The 69th meeting of the MGH Scientific Advisory Committee (SAC), on April 6 and 7, focused on the hospital’s five thematic research centers.
Medical laboratory professionals week – an annual celebration of laboratory professionals and pathologists who play a vital role in every aspect of health care – runs from April 24-30.
Many ‘keen minds’ have worked toward a better understanding of disease to enable improved diagnosis and treatment.
Back to Top